Companies That Aren’t Using AI to Elevate Their Comms Strategy Are Missing Out: Here’s Why

Dan Gebow, PhD, Chief Innovation Officer, Bioclinica talks about the role of AI in enhancing the efficiencies of clinical trials and making a swift shift to medtech
1. Can you tell us about your role at Bioclinica?
I am the Chief Innovation Officer at Bioclinica. I oversee the company’s imaging R&D teams as well as our Innovation Program. Bioclinica’s imaging core lab processes and reads over 40,000 medical images each month and we do it using our proprietary imaging systems. The innovation department is about 40 people strong and focused on inventing new technologies that increase the speed of clinical trials through novel technology, including artificial intelligence (AI).

You May Like More: